Dihydroergotamine mesilate (Pulmatrix)

N/A

Report date: 2025/11/28 15:37:23

Base Information

Drug NameDihydroergotamine mesilate (Pulmatrix)
Drug Alias NamePUR-3100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor agonistsSerotonin 1b (5-HT1b) receptor agonists
TargetsSerotonin 1d (5-HT1d) receptorSerotonin 1b (5-HT1b) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPulmatrix Inc
China Registration ClassN/A

Develop Information

Active CompaniesPulmatrix Inc
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG